
Bloomberg
FDA Drops Complaint Against Whoop’s Blood Pressure Tracking Tool
The US Food and Drug Administration dropped its complaint against fitness tracker brand Whoop Inc. over its blood-pressure tracking tool, marking an about-face after the agency initially asked the company to disable it.
View original source — Bloomberg ↗
Related stories

Bloomberg
BusinessJun 23, 2026 · 1 min
German Rail Halted Nationwide Services After Radio System Outage
Bloomberg

The Punch
BusinessJun 23, 2026 · 1 min
2026/27 NPFL champions to get ₦1bn prize money — NSC chairman
The Punch

The Punch
BusinessJun 23, 2026 · 1 min
My picture as election observer in Ekiti election AI generated — Edo APC Chair
The Punch

Bloomberg
BusinessJun 23, 2026 · 1 min
UAE Oil Exports Surge to 85% of Pre-War Levels, IEA Says
Bloomberg